Rapid dissemination of RET-transgene-driven melanoma in the presence of non-obese diabetic alleles: Critical roles of Dectin-1 and Nitric-oxide synthase type 2

References

• Swann JB, Smyth MJ. Immune surveillance of tumors. J Clin Invest 2007; 117:1137-46; PMID:17476343; http://dx.doi.org/10.1172/JCI31405
   PubMed Web of Science ®Google Scholar
• Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Curr Opin Genet Dev 2008; 18:11-8; PMID:18308558; http://dx.doi.org/10.1016/j.gde.2007.12.007
   PubMed Web of Science ®Google Scholar
• Pomerantz MM, Freedman ML. The Genetics of Cancer Risk. Cancer J 2011; 17:416-22; PMID:22157285; http://dx.doi.org/10.1097/PPO.0b013e31823e5387
   PubMed Web of Science ®Google Scholar
• Galvan A, Ioannidis JPA, Dragani TA. Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. Trends Genet 2010; 26:132-41; PMID:20106545; http://dx.doi.org/10.1016/j.tig.2009.12.008
   PubMed Web of Science ®Google Scholar
• Byrne HM. Dissecting cancer through mathematics: from the cell to the animal model. Nat Rev Cancer 2010; 10:221-30; PMID:20179714; http://dx.doi.org/10.1038/nrc2808
   PubMed Web of Science ®Google Scholar
• Kato M, Takahashi M, Akhand AA, Liu W, Dai Y, Shimizu S, Iwamoto T, Suzuki H, Nakashima I. Transgenic mouse model for skin malignant melanoma. Oncogene 1998; 17:1885-8; PMID:9778055; http://dx.doi.org/10.1038/sj.onc.1202077
   PubMed Web of Science ®Google Scholar
• Eyles J, Puaux AL, Wang X, Toh B, Prakash C, Hong M, Tan TG, Zheng L, Ong LC, Jin Y et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest 2010; 120:2030-9; PMID:20501944; http://dx.doi.org/10.1172/JCI42002
   PubMed Web of Science ®Google Scholar
• Lengagne R, Graff-Dubois S, Garcette M, Renia L, Kato M, Guillet JG, Engelhard VH, Avril MF, Abastado JP, Prevost-Blondel A. Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases. J Immunol 2008; 180:130-7; PMID:18097012; http://dx.doi.org/10.4049/jimmunol.180.1.130
   PubMed Web of Science ®Google Scholar
• Umansky V, Abschuetz O, Osen W, Ramacher M, Zhao F, Kato M, Schadendorf D. Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors. Cancer Res 2008; 68:9451-8; PMID:19010920; http://dx.doi.org/10.1158/0008-5472.CAN-08-1464
   PubMed Web of Science ®Google Scholar
• Kimpfler S, Sevko A, Ring S, Falk C, Osen W, Frank K, Kato M, Mahnke K, Schadendorf D, Umansky V. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs. J Immunol 2009; 183:6330-7; PMID:19841169; http://dx.doi.org/10.4049/jimmunol.0900609
   PubMed Web of Science ®Google Scholar
• Zhao F, Falk C, Osen W, Kato M, Schadendorf D, Umansky V. Activation of p38 Mitogen-Activated Protein Kinase Drives Dendritic Cells to Become Tolerogenic in Ret Transgenic Mice Spontaneously Developing Melanoma. Clin Cancer Res 2009; 15:4382-90; PMID:19549770; http://dx.doi.org/10.1158/1078-0432.CCR-09-0399
   PubMed Web of Science ®Google Scholar
• Lengagne R, Pommier A, Caron J, Douguet L, Garcette M, Kato M, Avril MF, Abastado JP, Bercovici N, Lucas B et al. T Cells Contribute to Tumor Progression by Favoring Pro-Tumoral Properties of Intra-Tumoral Myeloid Cells in a Mouse Model for Spontaneous Melanoma. PLoS One 2011; 6:e20235; PMID:21633700; http://dx.doi.org/10.1371/journal.pone.0020235
   PubMed Web of Science ®Google Scholar
• Toh B, Wang X, Keeble J, Sim WJ, Khoo K, Wong WC, Kato M, Prevost-Blondel A, Thiery JP, Abastado JP. Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor. PLoS Biol 2011; 9:e1001162; PMID:21980263; http://dx.doi.org/10.1371/journal.pbio.1001162
   PubMedGoogle Scholar
• Umansky V, Sevko A. Melanoma-induced immunosuppression and its neutralization. Semin Cancer Biol 2012; 22:319-26; PMID:22349515; http://dx.doi.org/10.1016/j.semcancer.2012.02.003
   PubMed Web of Science ®Google Scholar
• Pommier A, Audemard A, Durand A, Lengagne R, Delpoux A, Martin B, Douguet L, Le Campion A, Kato M, Avril M-F et al. Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells. Proc Natl Acad Sci U S A 2013; 110:13085-90; PMID:23878221; http://dx.doi.org/10.1073/pnas.1300314110
   PubMed Web of Science ®Google Scholar
• Tham M, Tan KW, Keeble J, Wang X, Hubert S, Barron L, Tan NS, Kato M, Prevost-Blondel A, Angeli V et al. Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation. Oncotarget 2014; 5:12027-42; PMID:25294815; http://dx.doi.org/10.18632/oncotarget.2482
   PubMed Web of Science ®Google Scholar
• Dragani TA, Peissel B, Zanesi N, Aloisi A, Dai Y, Kato M, Suzuki H, Nakashima I. Mapping of melanoma modifier loci in RET transgenic mice. Jpn J Cancer Res 2000; 91:1142-7; PMID:11092979; http://dx.doi.org/10.1111/j.1349-7006.2000.tb00897.x
   PubMedGoogle Scholar
• Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 1999; 5:601-4; PMID:10371488; http://dx.doi.org/10.1038/9442
   PubMed Web of Science ®Google Scholar
• Bernard NF, Ertug F, Margolese H. High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice. Diabetes 1992; 41:40-6; PMID:1727738; http://dx.doi.org/10.2337/diab.41.1.40
   PubMed Web of Science ®Google Scholar
• Markees TG, Serreze DV, Phillips NE, Sorli CH, Gordon EJ, Shultz LD, Noelle RJ, Woda BA, Greiner DL, Mordes JP et al. NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes 1999; 48:967-74; PMID:10331399; http://dx.doi.org/10.2337/diabetes.48.5.967
   PubMed Web of Science ®Google Scholar
• Alleva DG, Johnson EB, Wilson J, Beller DI, Conlon PJ. SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity. J Leukoc Biol 2001; 69:440-8; PMID:11261792
   PubMed Web of Science ®Google Scholar
• Prochazka M, Leiter EH, Serreze DV, Coleman DL. Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice. Science 1987; 237:286-9; PMID:2885918; http://dx.doi.org/10.1126/science.2885918
   PubMed Web of Science ®Google Scholar
• Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nat Rev Cancer 2013; 13:739-52; PMID:24060865; http://dx.doi.org/10.1038/nrc3581
   PubMed Web of Science ®Google Scholar
• Damuzzo V, Pinton L, Desantis G, Solito S, Marigo I, Bronte V, Mandruzzato S. Complexity and challenges in defining myeloid-derived suppressor cells: Defining Myeloid-Derived Suppressor Cells. Cytometry B Clin Cytom 2015; 88:77-91; PMID:25504825; http://dx.doi.org/10.1002/cyto.b.21206
   PubMed Web of Science ®Google Scholar
• Kato M, Liu W, Akhand AA, Dai Y, Ohbayashi M, Tuzuki T, Suzuki H, Isobe K, Takahashi M, Nakashima I. Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse lines. Oncogene 1999; 18:837-42; PMID:9989837; http://dx.doi.org/10.1038/sj.onc.1202329
   PubMed Web of Science ®Google Scholar
• Kato M, Liu W, Akhand AA, Hossain K, Takeda K, Takahashi M, Nakashima I. Ultraviolet radiation induces both full activation of ret kinase and malignant melanocytic tumor promotion in RFP-RET-transgenic mice. J Invest Dermatol 2000; 115:1157-8; PMID:11121157; http://dx.doi.org/10.1046/j.1523-1747.2000.0202a-2.x
   PubMed Web of Science ®Google Scholar
• Kato M, Takeda K, Kawamoto Y, Tsuzuki T, Hossain K, Tamakoshi A, Kunisada T, Kambayashi Y, Ogino K, Suzuki H et al. c-Kit-targeting immunotherapy for hereditary melanoma in a mouse model. Cancer Res 2004; 64:801-6; PMID:14871802; http://dx.doi.org/10.1158/0008-5472.CAN-03-2532
   PubMed Web of Science ®Google Scholar
• Rusmini M, Griseri P, Lantieri F, Matera I, Hudspeth KL, Roberto A, Mikulak J, Avanzini S, Rossi V, Mattioli G et al. Induction of RET Dependent and Independent Pro-Inflammatory Programs in Human Peripheral Blood Mononuclear Cells from Hirschsprung Patients. PLoS One 2013; 8:e59066; PMID:23527089; http://dx.doi.org/10.1371/journal.pone.0059066
   PubMedGoogle Scholar
• Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 2005; 23:447-85; PMID:15771578; http://dx.doi.org/10.1146/annurev.immunol.23.021704.115643
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Sakaguchi S. Regulatory T cells in cancer immunotherapy. Curr Opin Immunol 2014; 27:1-7; PMID:24413387; http://dx.doi.org/10.1016/j.coi.2013.12.005
   PubMed Web of Science ®Google Scholar
• Roychoudhuri R, Eil RL, Restifo NP. The interplay of effector and regulatory T cells in cancer. Curr Opin Immunol 2015; 33:101-11; PMID:25728990; http://dx.doi.org/10.1016/j.coi.2015.02.003
   PubMed Web of Science ®Google Scholar
• Muhl H, Pfeilschifter J. Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int Immunopharmacol 2003; 3:1247-55; PMID:12890422; http://dx.doi.org/10.1016/S1567-5769(03)00131-0
   PubMed Web of Science ®Google Scholar
• Kelchtermans H, Billiau A, Matthys P. How interferon-gamma keeps autoimmune diseases in check. Trends Immunol 2008; 29:479-86; PMID:18775671; http://dx.doi.org/10.1016/j.it.2008.07.002
   PubMed Web of Science ®Google Scholar
• MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15:323-50; PMID:9143691; http://dx.doi.org/10.1146/annurev.immunol.15.1.323
   PubMed Web of Science ®Google Scholar
• Niederkorn JY. Emerging concepts in CD8+ T regulatory cells. Curr Opin Immunol 2008; 20:327-31; PMID:18406591; http://dx.doi.org/10.1016/j.coi.2008.02.003
   PubMed Web of Science ®Google Scholar
• Parodi A., Battaglia FA, Kalli F, Ferrera F, Conteduca G, Tardito S, Stringara S, Ivaldi F, Negrini S, Borgonovo G et al. CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes. Cancer Immunol Immunother 2013; 62:851-62; PMID:23359087; http://dx.doi.org/10.1007/s00262-013-1392-z
   PubMed Web of Science ®Google Scholar
• Condamine T, Ramachandran I, Youn JI, Gabrilovich DI. Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells. Annu Rev Med 2015; 66:97-110; PMID:25341012; http://dx.doi.org/10.1146/annurev-med-051013-052304
   PubMed Web of Science ®Google Scholar
• Dambuza IM, Brown GD. C-type lectins in immunity: recent developments. Curr Opin Immunol 2015; 32:21-7; PMID:25553393; http://dx.doi.org/10.1016/j.coi.2014.12.002
   PubMed Web of Science ®Google Scholar
• Chiba S, Ikushima H, Ueki H, Yanai H, Kimura Y, Hangai S, Nishio J, Negishi H, Tamura T, Saijo S et al. Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses. ELife 2014; 3:e04177; PMID:25149452; http://dx.doi.org/10.7554/eLife.04177
   PubMed Web of Science ®Google Scholar
• Masuda Y, Inoue H, Ohta H, Miyake A, Konishi M, Nanba H. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice. Int J Cancer 2013; 133:108-19; PMID:23280601; http://dx.doi.org/10.1002/ijc.27999
   PubMed Web of Science ®Google Scholar
• Tian J, Ma J, Ma K, Guo H, Baidoo SE, Zhang Y, Yan J, Lu L, Xu H, Wang S. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells: Cellular immune response. Eur J Immunol 2013; 43:1220-30; PMID:23424024; http://dx.doi.org/10.1002/eji.201242841
   PubMed Web of Science ®Google Scholar
• Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 2009; 21:38-46; PMID:19230638; http://dx.doi.org/10.1016/j.coi.2009.01.009
   PubMed Web of Science ®Google Scholar
• Ho CC, Liao WY, Wang CY, Lu YH, Huang HY, Chen HY, Chan WK, Chen HW, Yang PC. TREM-1 Expression in Tumor-associated Macrophages and Clinical Outcome in Lung Cancer. Am J Respir Crit Care Med 2008; 177:763-70; PMID:18096709; http://dx.doi.org/10.1164/rccm.200704-641OC
   PubMed Web of Science ®Google Scholar
• Li J, J, Salcedo R, Mivechi NF, Trinchieri G, Horuzsko A. The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. Cancer Res 2012; 72:3977-86; PMID:22719066; http://dx.doi.org/10.1158/0008-5472.CAN-12-0938
   PubMed Web of Science ®Google Scholar
• Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer 2006; 6:521-34; PMID:16794635; http://dx.doi.org/10.1038/nrc1910
   PubMed Web of Science ®Google Scholar
• Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001; 2:907-16; PMID:11577346; http://dx.doi.org/10.1038/ni1001-907
   PubMed Web of Science ®Google Scholar
• Tian J, Ma J, Wang S, Yan J, Chen J, Tong J, Wu C, Liu Y, Ma B, Mao C et al. Increased expression of mGITRL on D2SC/1 cells by particulate β-glucan impairs the suppressive effect of CD4+CD25+ regulatory T cells and enhances the effector T cell proliferation. Cell Immunol 2011; 270:183-7; PMID:21636079; http://dx.doi.org/10.1016/j.cellimm.2011.05.003
   PubMed Web of Science ®Google Scholar
• Rothfuchs AG, Bafica A, Feng CG, Egen JG, Williams DL, Brown GD, Sher A. Dectin-1 Interaction with Mycobacterium tuberculosis Leads to Enhanced IL-12p40 Production by Splenic Dendritic Cells. J Immunol 2007; 179:3463-71; PMID:17785780; http://dx.doi.org/10.4049/jimmunol.179.6.3463
   PubMed Web of Science ®Google Scholar
• Simpson PB, Mistry MS, Maki RA, Yang W, Schwarz DA, Johnson EB, Lio FM, Alleva DG. Cutting Edge: Diabetes-Associated Quantitative Trait Locus, Idd4, Is Responsible for the IL-12p40 Overexpression Defect in Nonobese Diabetic (NOD) Mice. J Immunol 2003; 171:3333-7; PMID:14500624; http://dx.doi.org/10.4049/jimmunol.171.7.3333
   PubMed Web of Science ®Google Scholar
• MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81:641-50; PMID:7538909; http://dx.doi.org/10.1016/0092-8674(95)90085-3
   PubMed Web of Science ®Google Scholar